Thèse--Zurich. / Cirriculum vitae. "Bibliographie": p. [25].

Thesis (M.D.)--University of Pennsylvania, 1801. / Microform version available in the Readex Early American Imprints series.

Thesis (Ph. D.)--University of Minnesota, 1934. / Cover title. Vita. "Reprinted from the Archives of dermatology and syphilology October, 1934, vol. 30." Includes bibliographical references.

published_or_final_version / Biochemistry / Doctoral / Doctor of Philosophy

Thesis (MAppSc)--University of South Australia, 1997

Thesis (Ph. D.)--University of Hong Kong, 1998. / Includes bibliographical references (leaf 117-143).

Thesis (M.S.)--University of Wisconsin--Madison, 1967. / eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references.

Thesis (Ph. D.)--University of Wisconsin--Madison, 1967. / Typescript. Vita. eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references.

Thesis (M.S.)--University of Wisconsin--Madison, 1967. / Digitized and made available by the University of Wisconsin Digital Collections Center as part of Minds@UW. Description based on print version record. WU Includes bibliographical references.

This observational study was conducted to characterize those patients with lymphatic anomalies complicated by effusions, as well as factors that are associated with the occurrence of effusions and poor outcome. Furthermore, this research aimed to better describe the natural histories of patients presenting with effusions resulting from lymphatic disorders, including morbidity and mortality rates. Of a cohort of 230 registry patients, 145 registered patients suffering from lymphatic disorders who experienced at least one effusion during follow-up were eligible for inclusion in this study. Information was collected primarily from structured patient interviews, medical records, and interdisciplinary conference reviews and clinic visits at the Vascular Anomalies Center at Boston Children's Hospital. Among other characteristics, the age at presentation, the age at pulmonary presentation, concurrent symptoms and disease features were assessed. Of patients with effusions, 37% present with their first effusions within the first year of their lives. Of the deceased cohort of patients who presented with their first effusion in the first year of their lives, 66.67% also died within the first year of their lives. Overall mortality for those patients suffering from effusions was found to be 17% (25/145). Of the deceased cohort with a known cause of death, 53% died due to respiratory or pulmonary complications of effusions. The median number of years from effusion presentation until death was 2.04 years. These data collected implied effusions are a critical determinant of mortality in patients with disorders of the lymphatic system.